The use of protein phosphatase 2A activators in combination therapies for pancreas cancer
The use of protein phosphatase 2A activators in combination therapies for pancreas cancer |
|
https://doi.org/10.18632/oncotarget.26772
Brittany L. Allen-Petersen,
and Rosalie C. Sears
|
| 2008-2009 |
TET2 mutations and clonal dynamics
TET2 mutations and clonal dynamics |
|
https://doi.org/10.18632/oncotarget.26779
Ashwin Kishtagari,
Babal K. Jha,
and Jaroslaw P. Maciejewski
|
| 2010-2011 |
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer |
|
https://doi.org/10.18632/oncotarget.26769
Clelia Madeddu,
Paraskevas Kotsonis,
Fabrizio Lavra,
Giacomo Chiappe,
Luca Melis,
Ester Mura,
Mario Scartozzi,
and Antonio Macciò
|
| 2012-2021 |
Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil
Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil |
|
https://doi.org/10.18632/oncotarget.26770
Eloisa González-Lavado,
Lourdes Valdivia,
Almudena García-Castaño,
Fernando González,
Carmen Pesquera,
Rafael Valiente,
and Mónica L. Fanarraga
|
| 2022-2029 |
The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma
The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.26771
Benjamin J. Chen,
Ravi Dashnamoorthy,
Pallavi Galera,
Vladislav Makarenko,
Hong Chang,
Srimoyee Ghosh,
and Andrew M. Evens
|
| 2030-2040 |
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.26724
Chung-Ching Wang,
Dueng-Yuan Hueng,
Ai-Fang Huang,
Wei-Liang Chen,
Shih-Ming Huang,
and James Yi-Hsin Chan
|
| 2041-2054 |
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26725
Marie-Anne Goyette,
Rebecca Cusseddu,
Islam Elkholi,
Afnan Abu-Thuraia,
Nehme El-Hachem,
Benjamin Haibe-Kains,
Jean-Philippe Gratton,
and Jean-François Côté
|
| 2055-2067 |
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β |
|
https://doi.org/10.18632/oncotarget.26699
Ken Tawara,
Hannah Scott,
Jacqueline Emathinger,
Cody Wolf,
Dollie LaJoie,
Danielle Hedeen,
Laura Bond,
Paul Montgomery,
and Cheryl Jorcyk
|
| 2068-2085 |
Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model
Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model |
|
https://doi.org/10.18632/oncotarget.26747
Nir Pillar,
Avital Luba Polsky,
and Noam Shomron
|
| 2086-2094 |
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors |
|
https://doi.org/10.18632/oncotarget.26777
Musaffe Tuna,
Christopher I. Amos,
and Gordon B. Mills
|
| 2095-2111 |
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression |
|
https://doi.org/10.18632/oncotarget.26801
Jian Ma,
Yanxin Fan,
Tingting Feng,
Fangjun Chen,
Zhipeng Xu,
Suqing Li,
Qingfeng Lin,
Xiaoting He,
Weihong Shi,
Yang Liu,
Zhihua Liu,
Bin Zhu,
and Xiufeng Cao
|
| 2112-2112 |
Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors |
|
https://doi.org/10.18632/oncotarget.26802
N. Andres Parra,
Hong Lu,
Qian Li,
Radka Stoyanova,
Alan Pollack,
Sanoj Punnen,
Jung Choi,
Mahmoud Abdalah,
Christopher Lopez,
Kenneth Gage,
Jong Y. Park,
Yamoah Kosj,
Julio M. Pow-Sang,
Robert J. Gillies,
and Yoganand Balagurunathan
|
| 2113-2113 |
